SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival
- 21 May 2009
- journal article
- Published by Springer Nature in Leukemia
- Vol. 23 (10) , 1929-1932
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase PolymorphismJournal of Clinical Oncology, 2007
- Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)Blood, 2006
- Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoterHuman Genetics, 2006
- The International HapMap ProjectNature, 2003
- Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemiaBlood, 2002
- Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisBlood, 2002
- Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemiaBritish Journal of Haematology, 2001
- Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndromeLeukemia, 2000
- dbSNP: a database of single nucleotide polymorphismsNucleic Acids Research, 2000
- Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytesBlood, 1975